欧洲共同体中源自生物技术的兽用药品的上市许可程序。 - Suppr

The procedure for marketing authorization for veterinary medicinal products derived from biotechnology in the European community.

Brunko P

Pharmaceuticals Unit, Commission of the European Communities, Brussels.

Dev Biol Stand. 1992;79:11-5.

Abstract

摘要

Dev Biol Stand. 1992;79:11-5.

Regul Toxicol Pharmacol. 1997 Aug;26(1 Pt 1):129-33. doi: 10.1006/rtph.1997.1103.

Biologicals. 1994 Dec;22(4):307-11. doi: 10.1006/biol.1994.1045.

Dev Biol (Basel). 2004;118:3-10.

Dev Biol Stand. 1992;79:31-6.

Dev Biol Stand. 1992;79:65-74.

J Vet Pharmacol Ther. 2005 Apr;28(2):131-47. doi: 10.1111/j.1365-2885.2005.00645.x.

Rev Sci Tech. 2007 Aug;26(2):415-20.

Rev Sci Tech. 2007 Apr;26(1):135-45.

Tijdschr Diergeneeskd. 2006 Jul 1;131(13):496.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。